Vilin Bio Med Ltd.

42.60+2.0 (+4.80%)

27 Jul, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Vilin Bio Med Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR
Total Revenue	16.81	11.72	11.21	12.31	15.80	14.81
Cost of Operating Revenue	14.03	9.30	9.09	7.34	13.14	13.58
Gross Profit	2.78	2.42	2.13	4.97	2.67	1.23
Gross Margin	16.5	20.7	19.0	40.4	16.9	8.3
Total Operating Expenses	16.23	11.12	10.67	9.91	15.12	14.13
Operating Profit	0.59	0.60	0.55	2.41	0.69	0.68
Operating Margin	3.5	5.1	4.9	19.5	4.3	4.6
Financing Income/(Expense) - Net	-0.39	-0.44	-0.50	-0.62	-0.46	-0.38
Profit before Taxes	0.19	0.16	0.04	1.78	0.23	0.31
Income Taxes	0.03	0.04	0.01	0.54	0.06	0.08
Profit after Tax	0.16	0.12	0.03	1.24	0.16	0.22
PAT Margin	1.0	1.0	0.3	10.1	1.0	1.5
EPS - Basic - ex Extraordinary Items	0.12	0.09	0.02	1.25	0.12	0.16
EPS - Diluted - ex Extraordinary Items	0.12	0.09	0.02	1.25	0.12	0.16
EBIT	0.59	0.60	0.55	2.41	0.69	0.68
EBITDA	0.90	0.86	0.77	2.57	0.82	0.79
EBITDA Margin	5.3	7.3	6.8	20.9	5.2	5.3

Balance Sheet

Abridged

Understanding Balance Sheet

Vilin Bio Med Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Source:	PR	PR	PR	AR	AR	AR
Total Current Assets	11.83	11.97	11.86	13.28	18.62	12.56
Long-Term Investments	-	-	-	-	-	-
Property Plant & Equipment - Net	2.13	1.87	1.65	1.51	1.38	2.85
Total Non-Current Assets	2.17	1.92	1.70	4.40	13.79	15.17
Total Assets	14.01	13.89	13.56	17.68	32.40	27.73
Total Current Liabilities	6.71	5.46	5.37	6.50	9.27	4.57
Long Term Debt	-	1.02	0.73	0.43	0.21	-
Total Non-Current Liabilities	0.06	1.07	0.79	0.50	0.29	0.09
Total Liabilities	6.76	6.53	6.16	7.01	9.56	4.66
Total Shareholders' Equity	7.24	7.36	7.40	10.68	22.84	23.06
Total Equity	7.24	7.36	7.40	10.68	22.84	23.06
Total Liabilities & Equity	14.01	13.89	13.56	17.68	32.40	27.73

Cash Flow

Abridged

Understanding Cash Flow Statement

Vilin Bio Med Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	0.47	0.38	0.25	1.41	0.30	0.34
Working Capital - Increase/(Decrease)	-1.93	-1.38	-0.05	-3.07	-6.07	-0.50
Net CF from Operating Activities	-1.46	-1.00	0.21	-1.66	-5.76	-0.16
Capital Expenditures - Net	0.02	-	-	0.03	0.00	1.57
Net CF from Investing Activities	-0.02	-	-	-0.03	0.00	-1.57
Stock - Issuance/(Retirement) - Net	-	-	-	2.04	12.00	-
Debt - LT & ST - Issuance/(Retirement) - Total	1.51	0.98	-0.22	-0.36	-0.22	-4.26
Net Cash Flow from Financing Activities	1.51	0.98	-0.22	1.68	11.78	-4.26
Free Cash Flow to Equity	0.03	-0.02	-0.01	-2.04	-5.99	-5.99
Free Operating CF net dividend	-1.48	-1.00	0.21	-1.69	-5.76	-1.74
Free Operating CF	-1.48	-1.00	0.21	-1.69	-5.76	-1.74

Business Segment Analysis

Vilin Bio Med Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Vilin Bio Med Ltd.

Regional Segment Analysis

Vilin Bio Med Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Vilin Bio Med Ltd.

Historical Segment Analysis

Track how Vilin Bio Med Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Vilin Bio Med Ltd.

Frequently Asked Questions

What is the revenue of Vilin Bio Med Ltd.?

The latest trailing twelve month revenue of Vilin Bio Med Ltd. is ₹ 14.81 Cr, reflecting a 1-year growth of -6.30% and a 3-year CAGR of 9.71%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Vilin Bio Med Ltd.?

The latest trailing twelve month net profit (PAT) of Vilin Bio Med Ltd. is ₹ 0.22 Cr, with a 3-year earnings CAGR of 88.29%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Vilin Bio Med Ltd.?

The trailing twelve month EBITDA of Vilin Bio Med Ltd. is approximately ₹ 0.68 Cr (based on an operating margin of 4.61%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Vilin Bio Med Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Vilin Bio Med Ltd. is 0.16. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Vilin Bio Med Ltd.?

The debt-to-equity ratio of Vilin Bio Med Ltd. stands at 0.02. The interest coverage ratio is 0.83x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Vilin Bio Med Ltd.?

The book value per share of Vilin Bio Med Ltd. is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of Vilin Bio Med Ltd.?

The trailing twelve month operating cash flow of Vilin Bio Med Ltd. is ₹ 1.91 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Vilin Bio Med Ltd. report consolidated or standalone financials?

Vilin Bio Med Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.